Inactive Instrument

Press Releases HumanOptics AG

Equities

H9O1

DE000A1MMCR6

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

HumanOptics AG: Merger Squeeze-out registered	21-11-12	EQ
HumanOptics AG: Cash compensation for merger squeeze-out determined at EUR 8.71 per share	21-05-22	EQ
HumanOptics AG: Raising of earnings forecast for financial year 2020/2021	21-05-19	EQ
HumanOptics : Request by the main shareholder to execute a merger squeeze-out	21-01-21	PU
HumanOptics AG: Request by the main shareholder to execute a merger squeeze-out	21-01-21	EQ
HumanOptics : appointed Stefan Kremer as the new Chief Executive Officer (CEO)	21-01-15	EQ
HumanOptics AG : Notification and public disclosure of transactions by persons	20-12-30	EQ
Preliminary business figures 2019/2020: Effects of COVID 19 pandemic weigh on sales and earnings	20-08-27	PU
HumanOptics AG: Preliminary business figures 2019/2020: Effects of COVID 19 pandemic weigh on sales and earnings	20-08-27	EQ
HumanOptics AG: Dr. Pierre Billardon leaves the Management Board on 30 April 2020; Diana Bachmann appointed as his successor	20-04-20	EQ
HumanOptics AG: Capital increase from authorized capital with subscription rights excluded against cash contribution planned; sustainable strengthening of equity capital basis	20-03-18	EQ
HumanOptics AG: CE-marking for innovative trifocal lens TRIVA(R)	20-02-19	EQ
HumanOptics AG: Correction of the expected earnings forecast for the current financial year 2019/2020	20-02-10	EQ
HumanOptics AG: Artificial iris from HumanOptics receives US health insurance approval	20-01-23	EQ
HumanOptics AG: Person of Chinese investor now known as indirect majority shareholder of HumanOptics AG	19-12-19	EQ
HumanOptics AG: Chinese investor new majority shareholder of HumanOptics AG - Closing of the share purchase agreement dated 30 August 2019 between Medipart AG and a Chinese investor regarding the majority stake in HumanOptics AG	19-12-18	EQ
HumanOptics AG: Majority stake in HumanOptics AG to be sold to Chinese investor	19-08-30	EQ
HumanOptics AG: Capital increase from authorized capital planned with exclusion of subscription rights; sustainable strengthening of equity base through conversion of liabilities	18-11-30	EQ
HumanOptics : Artificial Iris of HumanOptics Received FDA Approval	18-06-05	PU
HumanOptics : Artificial Iris of HumanOptics Received FDA Approval	18-05-31	EQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases HumanOptics AG

Equities

H9O1

DE000A1MMCR6

Press Releases

Filters